Product correctly added to cart.

discount label
EOAI3402143
View 3D

Biosynth logo

EOAI3402143

CAS: 1699750-95-2

Ref. 3D-ZSC75095

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 21 Jun 2024

Product Information

Name:
EOAI3402143
Description:

EOAI3402143 is a research chemical that has various characteristics and potential applications. It is a creatine derivative that contains brominated compounds. This chemical has been studied for its antioxidant activity and its potential role in managing acidosis. Additionally, EOAI3402143 has shown cytotoxic properties, indicating its potential as an anti-cancer agent.

Studies have also revealed that EOAI3402143 forms a complex with zinc and tartaric acid, which may enhance its antioxidant and cytotoxic effects. Furthermore, this compound contains an aldehyde group, suggesting possible reactivity with other molecules.

Overall, EOAI3402143 is a promising research chemical with diverse characteristics and potential applications in the fields of medicine and biochemistry. Further studies are needed to fully understand its mechanisms of action and explore its therapeutic potential.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
503.42 g/mol
Formula:
C25H28Cl2N4O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-ZSC75095 EOAI3402143

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".